Business

Tilray-nasdaq

Share price of Canopy Growth and Tilray each fall 6.5 percent in same week quarterly results released

The weed industry has been dogged by a lack of public enthusiasm for cannabis beverages and regulators’ unwillingness to embrace CBD

0
More-Life

Less Life? Canopy’s partnership with Drake not progressing as planned

CEO David Klein says the More Life project is not high on his list of priorities

0
earnings season five trading days quarterly report

Earnings season fails to excite cannabis investors over last five trading days

In the wake of a Cronos Group quarterly report, most Canadian companies’ share prices took a tumble.

0
Cronos Group quarterly report

Cronos Group records $107.7-million loss from April to June

On the upside, the Toronto-based weed company is now selling its Peace Naturals dried flower products to medical patients in Israel

0

Prospect of Biden presidency boosts U.S. cannabis stocks

The share prices of Curaleaf Holdings, Harvest Health & Recreation, and Acreage Holdings all rose more than 10 percent this week.

0

Rules around celebrity cannabis brands and endorsements differ in Canada and the U.S.

Canada’s rules around celebrity branding seem pretty cut and dried: it’s a no-no

0